UniProt ID | 2ABA_HUMAN | |
---|---|---|
UniProt AC | P63151 | |
Protein Name | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform | |
Gene Name | PPP2R2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 447 | |
Subcellular Localization | ||
Protein Description | The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.. | |
Protein Sequence | MAGAGGGNDIQWCFSQVKGAVDDDVAEADIISTVEFNHSGELLATGDKGGRVVIFQQEQENKIQSHSRGEYNVYSTFQSHEPEFDYLKSLEIEEKINKIRWLPQKNAAQFLLSTNDKTIKLWKISERDKRPEGYNLKEEDGRYRDPTTVTTLRVPVFRPMDLMVEASPRRIFANAHTYHINSISINSDYETYLSADDLRINLWHLEITDRSFNIVDIKPANMEELTEVITAAEFHPNSCNTFVYSSSKGTIRLCDMRASALCDRHSKLFEEPEDPSNRSFFSEIISSISDVKFSHSGRYMMTRDYLSVKIWDLNMENRPVETYQVHEYLRSKLCSLYENDCIFDKFECCWNGSDSVVMTGSYNNFFRMFDRNTKRDITLEASRENNKPRTVLKPRKVCASGKRKKDEISVDSLDFNKKILHTAWHPKENIIAVATTNNLYIFQDKVN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGAGGGND ------CCCCCCCCC | 19.28 | 22223895 | |
33 | Phosphorylation | AEADIISTVEFNHSG HHCCEEEEEEECCCC | 17.41 | 20071362 | |
62 | Acetylation | FQQEQENKIQSHSRG EECCCCCCCCCCCCC | 41.17 | 23236377 | |
62 | Ubiquitination | FQQEQENKIQSHSRG EECCCCCCCCCCCCC | 41.17 | 21890473 | |
62 | Ubiquitination | FQQEQENKIQSHSRG EECCCCCCCCCCCCC | 41.17 | 21890473 | |
68 | Methylation | NKIQSHSRGEYNVYS CCCCCCCCCCCCHHH | 36.22 | 115488577 | |
72 | Ubiquitination | SHSRGEYNVYSTFQS CCCCCCCCHHHCCCC | 23.19 | 21890473 | |
72 (in isoform 2) | Ubiquitination | - | 23.19 | - | |
88 | Acetylation | EPEFDYLKSLEIEEK CCCCCCHHHHCHHHH | 46.92 | 20167786 | |
88 | Ubiquitination | EPEFDYLKSLEIEEK CCCCCCHHHHCHHHH | 46.92 | 21890473 | |
95 | Ubiquitination | KSLEIEEKINKIRWL HHHCHHHHHHHCCCC | 38.50 | - | |
98 | Acetylation | EIEEKINKIRWLPQK CHHHHHHHCCCCCCC | 36.80 | 20167786 | |
105 | Acetylation | KIRWLPQKNAAQFLL HCCCCCCCCHHHHHH | 46.76 | 25953088 | |
105 | Ubiquitination | KIRWLPQKNAAQFLL HCCCCCCCCHHHHHH | 46.76 | 21890473 | |
105 | Ubiquitination | KIRWLPQKNAAQFLL HCCCCCCCCHHHHHH | 46.76 | 21890473 | |
115 (in isoform 2) | Ubiquitination | - | 45.46 | - | |
115 | Ubiquitination | AQFLLSTNDKTIKLW HHHHHCCCCCEEEEE | 45.46 | 21890473 | |
117 | Ubiquitination | FLLSTNDKTIKLWKI HHHCCCCCEEEEEEE | 54.97 | 21890473 | |
117 | 2-Hydroxyisobutyrylation | FLLSTNDKTIKLWKI HHHCCCCCEEEEEEE | 54.97 | - | |
123 | Ubiquitination | DKTIKLWKISERDKR CCEEEEEEEECCCCC | 46.95 | - | |
129 | Ubiquitination | WKISERDKRPEGYNL EEEECCCCCCCCCCC | 75.87 | 21890473 | |
137 | Ubiquitination | RPEGYNLKEEDGRYR CCCCCCCCCCCCCCC | 56.25 | 21890473 | |
143 | Phosphorylation | LKEEDGRYRDPTTVT CCCCCCCCCCCCCEE | 25.54 | 23917254 | |
147 | Phosphorylation | DGRYRDPTTVTTLRV CCCCCCCCCEEEEEE | 37.88 | 20068231 | |
148 | Phosphorylation | GRYRDPTTVTTLRVP CCCCCCCCEEEEEEE | 22.65 | 20068231 | |
153 | Phosphorylation | PTTVTTLRVPVFRPM CCCEEEEEEEECCCH | 28.71 | 27642862 | |
167 | Phosphorylation | MDLMVEASPRRIFAN HHEEEECCCCEEEEC | 12.87 | 21815630 | |
230 | Phosphorylation | EELTEVITAAEFHPN HHHHHEEHHHHCCCC | 25.62 | 23879269 | |
266 | Phosphorylation | SALCDRHSKLFEEPE HHHHHHHHHHHCCCC | 31.76 | 28348404 | |
267 | Ubiquitination | ALCDRHSKLFEEPED HHHHHHHHHHCCCCC | 51.58 | 21890473 | |
267 | Acetylation | ALCDRHSKLFEEPED HHHHHHHHHHCCCCC | 51.58 | 25953088 | |
276 | Phosphorylation | FEEPEDPSNRSFFSE HCCCCCCCCCHHHHH | 58.14 | 25627689 | |
277 (in isoform 2) | Ubiquitination | - | 49.34 | - | |
278 | Methylation | EPEDPSNRSFFSEII CCCCCCCCHHHHHHH | 38.90 | 115488585 | |
279 | Phosphorylation | PEDPSNRSFFSEIIS CCCCCCCHHHHHHHH | 34.59 | 25627689 | |
292 | Ubiquitination | ISSISDVKFSHSGRY HHHHHCCEECCCCCE | 46.25 | - | |
332 | Ubiquitination | VHEYLRSKLCSLYEN HHHHHHHHHHHHHCC | 47.26 | - | |
335 | Phosphorylation | YLRSKLCSLYENDCI HHHHHHHHHHCCCCC | 44.41 | 27251275 | |
355 | Phosphorylation | CCWNGSDSVVMTGSY EECCCCCEEEEECCC | 20.50 | - | |
359 | Phosphorylation | GSDSVVMTGSYNNFF CCCEEEEECCCCCCE | 16.03 | - | |
378 | Phosphorylation | RNTKRDITLEASREN CCCCCCEEEHHHHHC | 23.88 | 20068231 | |
382 | Phosphorylation | RDITLEASRENNKPR CCEEEHHHHHCCCCC | 30.65 | 23401153 | |
387 | Ubiquitination | EASRENNKPRTVLKP HHHHHCCCCCEEECC | 47.67 | - | |
390 | Phosphorylation | RENNKPRTVLKPRKV HHCCCCCEEECCCEE | 38.42 | 28555341 | |
397 (in isoform 2) | Ubiquitination | - | 3.30 | - | |
402 | Acetylation | RKVCASGKRKKDEIS CEECCCCCCCCCCEE | 59.56 | 15605981 | |
404 | Ubiquitination | VCASGKRKKDEISVD ECCCCCCCCCCEEEC | 68.97 | 21890473 | |
405 | Ubiquitination | CASGKRKKDEISVDS CCCCCCCCCCEEECC | 65.70 | - | |
409 | Phosphorylation | KRKKDEISVDSLDFN CCCCCCEEECCCCCC | 20.16 | 20873877 | |
412 | Phosphorylation | KDEISVDSLDFNKKI CCCEEECCCCCCHHH | 27.90 | 20873877 | |
417 | Acetylation | VDSLDFNKKILHTAW ECCCCCCHHHHHHCC | 40.98 | 26051181 | |
417 | Ubiquitination | VDSLDFNKKILHTAW ECCCCCCHHHHHHCC | 40.98 | 21890473 | |
417 | 2-Hydroxyisobutyrylation | VDSLDFNKKILHTAW ECCCCCCHHHHHHCC | 40.98 | - | |
418 | Ubiquitination | DSLDFNKKILHTAWH CCCCCCHHHHHHCCC | 52.16 | - | |
440 | Phosphorylation | VATTNNLYIFQDKVN EEECCCEEEEECCCC | 11.21 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of 2ABA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 2ABA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 2ABA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |